Rubella vaccine (Beijing Tiantan Biological Products)

风疹减毒活疫苗（北京天坛生物制品公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRubella vaccine (Beijing Tiantan Biological Products)
Drug Alias NameRubella Vaccine (Human Diploid Cell),Live
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubella
Global Approved IndicationsRubella
Approved Indications in ChinaRubella
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Tiantan Biological Products Corporation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRubella
Inactive IndicationsN/A

Other Information

ATC CodeJ07BJ01
Related LinksN/A